Skip to main content

Table 2 Clinical characteristics of patients with PE and PTL control pregnancies in placenta study

From: circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblasts

Characteristic

PE (n = 30)

Control (n = 30)

P-value

Maternal Age (year)

32.23 ± 4.16

31.55 ± 6.24

0.210

Pre-pregnancy BMI (kg/m2)

22.92 ± 3.07

22.51 ± 2.16

0.079

Gestational age (week)

34.61 ± 3.83

34.23 ± 2.11

0.470

Systolic (mmHg)

155.66 ± 15.54

118.72 ± 8.72

<  0.05

Diastolic (mmHg)

103.01 ± 7.73

79.66 ± 3.91

< 0.05

Proteinuria (>  0.3 g/24 h, n, %)

100 (100%)

0 (0%)

>  0.05

Smoking (n, %)

0 (0%)

0 (0%)

>  0.05

New-born weight (g)

2433.75 ± 538.19

2512.7 ± 681.46

0.088

  1. PE preeclampsia, BMI body mass index, PTL unexplained preterm labour